|
Diabetes Care, Vol 15, Issue 8 1009-1013, Copyright © 1992 by American Diabetes Association
Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr
O Snorgaard, LH Lassen and C Binder
Steno Memorial and Hvidore Hospital, Gentofte, Denmark.
OBJECTIVE--To study the natural history of beta-cell function from onset of
IDDM to expected deterioration of insulin (C-peptide) secretion and to
identify different patterns of decline, if any. RESEARCH DESIGN AND
METHODS--A cohort of 204 consecutive newly diagnosed IDDM (clinical
criteria) patients were followed prospectively for 7.4 yr (range 6-9 yr),
measuring fasting C-peptide at onset, 1, 3, 6, 9, 12, and then every 6 mo
until 106 wk (range 104-135 wk). Then, postprandial C-peptide was measured.
RESULTS--Fasting C-peptide was 0.17 nM (range 0.11-0.25 nM) at onset
followed by an annual increase rate of 0.16 nM/yr (range 0.06-0.48 nM/yr)
to a peak of 0.28 nM (range 0.23-0.34 nM/yr) after 25 wk (range 12-39 wk).
The subsequent annual decline rate of fasting C-peptide was 0.08
(0.05-0.12) and of postprandial C-peptide 0.03 nM/yr (range 0.02-0.06
nM/yr). None of these parameters showed bimodality in their distribution.
However, some parameters were important. In men, fasting C-peptide at onset
was lower, but the initial C-peptide increase rate was more pronounced
compared to women. Furthermore, insulin-free remission was related to
higher C-peptide levels throughout the study. C-peptide was higher during
the 1st yr of diabetes in subjects greater than 30 yr of age at onset
compared with younger diabetic patients. Stepwise multiple regression
analysis showed that age, male sex, and fasting C-peptide at onset were of
some predictive value for the C-peptide levels at 5 yr. However, simple
group comparisons revealed no significant differences. CONCLUSIONS--No
major heterogeneity exists in the pattern of decline of beta-cell function
in IDDM, although small differences in pattern could be identified in both
sexes, in different age-groups, and in relation to achieving insulin-free
remission.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Sosenko, J. P. Palmer, L. Rafkin-Mervis, J. P. Krischer, D. Cuthbertson, D. Matheson, and J. S. Skyler
Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
Diabetes Care,
November 1, 2008;
31(11):
2188 - 2192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Sherry, E. B. Tsai, and K. C. Herold
Natural History of {beta}-Cell Function in Type 1 Diabetes
Diabetes,
December 1, 2005;
54(suppl_2):
S32 - S39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bruno, F. Cerutti, F. Merletti, P. Cavallo-Perin, E. Gandolfo, M. Rivetti, C. Runzo, S. Pinach, G. Pagano, and The Piedmont Study Group for Diabetes Epidemiology
Residual {beta}-Cell Function and Male/Female Ratio Are Higher in Incident Young Adults Than in Children: The registry of type 1 diabetes of the province of Turin, Italy, 1984-2000
Diabetes Care,
February 1, 2005;
28(2):
312 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Steele, W. A. Hagopian, S. Gitelman, U. Masharani, M. Cavaghan, K. I. Rother, D. Donaldson, D. M. Harlan, J. Bluestone, and K. C. Herold
Insulin Secretion in Type 1 Diabetes
Diabetes,
February 1, 2004;
53(2):
426 - 433.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes,
January 1, 2004;
53(1):
250 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al.
Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes
J. Clin. Endocrinol. Metab.,
December 1, 2000;
85(12):
4619 - 4623.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1992 by the American Diabetes Association.
|
|
| |
|